GO
Loading...

Rudolph Technologies Inc

  • --Abiomed Inc rescheduled second-quarter conference call to Nov. 1 at 8 am Eastern Time. --Accelrys Inc rescheduled third-quarter results to Oct. 31, after market. Its conference call will be held on Nov. 1, 9.30 am Eastern Time.

  • --Acorda Therapeutics Inc: rescheduled third-quarter financial results and conference call to Oct. 31 from Oct. 30. --Advent Software Inc reschedules third-quarter results and conference call to Oct. 30. --AGCO Corp rescheduled third-quarter results to Oct 31, 8 am Eastern Time from Oct. 30.

  • --Martha Stewart Living Omnimedia Inc rescheduled third-quarter results to Nov. 1 from Oct. 30. --Vertex Pharmaceuticals Inc rescheduled third-quarter 2012 earnings and conference call to after markets close on Nov. 1 from Oct. 29. --The McGraw-Hill Companies Inc rescheduled third-quarter earnings and conference call to Nov. 2 from Oct. 31.

  • Oct 1- Rudolph Technologies Inc:. *Credit Suisse raises Rudolph Technologies to outperform from neutral For a summary of rating and price target changes on U.S. companies:. Reuters Station users, click. 1568.

  • Chipmakers Signaling Bottom as Stocks Rebound Thursday, 26 Jan 2012 | 2:00 PM ET

    Several chipmakers this quarter turned in tepid earnings reports and weak outlooks, but some strategists say the industry may be nearing a bottom and there's still further room for upside in the stocks.

Most Popular Video

Thursday, 24 Apr 2014 | 4:03 PM ET

Microsoft is reporting Q3 EPS of $0.68 on revenue of $20.40 billion, with CNBC's Josh Lipton.

Thursday, 24 Apr 2014 | 12:41 PM ET

CNBC's Meg Tirrell reports a Cowen analyst is suggesting Allergan buy ADHD drug maker Shire. The FMHR traders, provide perspective.

Thursday, 24 Apr 2014 | 2:30 PM ET

Sell in May? It's an old cliché but the problem is it's sometimes right! But earnings keep rolling in better than expected. CNBC's Patti Domm explains.